Evidence suggested that haplotype polymorphisms of Taq1A and -141c Ins/Del DRD2 genes contributed to DRD2 antagonist resistance, especially linked to anxiety and depressive symptoms in schizophrenia (Kondo et al., 2003). The gene discussed is DRD2; the disease is Anxiety.